Emerade - information for patients
A new letter and information sheet has been produced for patients by the Medicines & Healthcare products Regulatory Agency (MHRA). There has been a further alert issued with regards to the activation of some Emerade pens. The surgery has recently contacted all patients with a fact sheet about Emerade. Below is a link to the new information released on 3rd October 2019.
Emerade Information Sheet
If you have any queries about your Emerade pens, please do not hesitate to contact your pharmacy or the surgery.
Gabapentin / Pregabalin prescribing